Liufang Tech specializes in the development and production of silicon carbide (SiC) technology, primarily focusing on its application in the semiconductor industry. The company offers a range of products, including chemical vapor deposition (CVD) silicon carbide coatings, graphite components, and tantalum carbide-coated products. These materials are pivotal in the production of semiconductor chips, particularly in sectors such as LED, SiC, gallium nitride (GaN), and monocrystalline silicon epitaxy. By providing hard and high-temperature resistant materials, Liufang Tech aims to enhance the performance and durability of semiconductor applications for its clients.
Immunowake is a biotechnology company dedicated to developing innovative therapies for patients who do not respond to conventional immunotherapies. The company is focused on creating a universal cancer vaccine that aims to generate safer and more effective bi-specific antibodies. By activating the body’s immune system, particularly antigen-specific T-cells, Immunowake seeks to enhance the ability to identify and eliminate cancer cells. This approach not only aims to improve treatment outcomes for patients with limited options but also strives to reduce toxicity associated with existing therapies while maintaining significant anti-tumor efficacy.
Developer of production automation systems for the semiconductor industry. The company focuses on the development of overall automated systems for 8-inch and 12-inch wafer manufacturing FABs in the semiconductor wafer manufacturing and semiconductor packaging and testing fields, enabling semiconductor manufacturers to reduce operation costs and stay competitive.
Accro Bioscience is a biotechnology company that develops innovative small molecule drugs aimed at treating inflammatory and autoimmune diseases, as well as cancer. The company specializes in researching the molecular mechanisms of regulated cell death, including necroptosis, pyroptosis, and ferroptosis. By understanding these processes and their roles in disease pathogenesis, Accro Bioscience seeks to enhance current therapeutic standards in targeted disease areas, contributing to advancements in treatment options for patients.
Innoforce Pharmaceuticals Co., Ltd, a biopharmaceutical company, engages in the development and commercialization of biomedicines and therapies. It develops cell and gene therapies, medicines, and antibodies. It also operates biologic process development laboratories. The company was founded in 2018 and is based in Hangzhou, China.
Inmagene Biopharmaceuticals Co. Ltd., founded in 2019 and headquartered in Shanghai, China, is a clinical-stage biotechnology company dedicated to researching and developing novel therapeutics for immunological and inflammatory diseases. The company focuses on creating innovative biomedical drugs to assist patients and healthcare providers in addressing immune-related conditions. Its product pipeline includes IMG-020, a protein drug designed to target IL-17A, developed by integrating Affibody’s protein therapeutics platform for enhanced potency and Albumod technology for extended half-life. Inmagene also has additional offices in Hangzhou and Beijing, China, further supporting its commitment to advancing healthcare solutions in the field of immunology.
Innoforce Pharmaceuticals Co., Ltd, a biopharmaceutical company, engages in the development and commercialization of biomedicines and therapies. It develops cell and gene therapies, medicines, and antibodies. It also operates biologic process development laboratories. The company was founded in 2018 and is based in Hangzhou, China.
Cullgen Inc. is a biopharmaceutical company based in San Diego, California, established in 2018. The company focuses on developing innovative new chemical entities (NCEs) aimed at treating diseases that currently lack effective therapeutic options. Utilizing its proprietary uSMITE™ platform, Cullgen employs targeted protein degradation technology to selectively degrade disease-causing proteins. This approach is particularly significant for addressing cancer, inflammatory, and autoimmune diseases, including targets that have been deemed undruggable. By providing novel therapeutic strategies, Cullgen aims to enhance drug discovery and offer new avenues for treating debilitating conditions.
Drug Farm is a China and US-based biotech developing innovative treatments targeting innate immunity for HBV, cancer, and autoimmune diseases. Drug Farm's unique IDInVivo platform combines breakthrough technologies in genetics and AI to discover new treatments.
Inmagene Biopharmaceuticals Co. Ltd., founded in 2019 and headquartered in Shanghai, China, is a clinical-stage biotechnology company dedicated to researching and developing novel therapeutics for immunological and inflammatory diseases. The company focuses on creating innovative biomedical drugs to assist patients and healthcare providers in addressing immune-related conditions. Its product pipeline includes IMG-020, a protein drug designed to target IL-17A, developed by integrating Affibody’s protein therapeutics platform for enhanced potency and Albumod technology for extended half-life. Inmagene also has additional offices in Hangzhou and Beijing, China, further supporting its commitment to advancing healthcare solutions in the field of immunology.
CARsgen Therapeutics, Ltd., a clinical-stage immunotherapy company, develops and commercializes chimeric antigen receptor T-cell (CAR-T) therapeutics for treating cancers. It offers CAR-T Technology that directs T cells to recognize cancer cells based on expression of specific cell surface proteins to treat solid and hematologic tumors. The company’s CAR-T cells target the GPC3 receptor for the treatment of late-stage hepatocellular carcinoma (HCC, or liver cancer) and lung squamous cell carcinoma (a common type of lung cancer). CARsgen Therapeutics, Ltd. is based in Shanghai, China.
Shanghai Zhuishi Technology Co., Ltd., founded in 2019, specializes in the research and development of low-speed autonomous driving technology. Based in Shanghai, China, the company focuses on creating autonomous driving systems and solutions tailored for automotive manufacturers. Zhuishi Technology aims to advance the capabilities of self-driving vehicles, contributing to the evolution of transportation through innovative technology.
GenFleet Therapeutics, based in Shanghai, China, is a biotechnology company focused on the research and development of therapeutic molecules aimed at cancer treatment. Founded in 2017, the company specializes in creating innovative pharmaceuticals and antibody drugs that target various cancer systems. Its efforts are directed at reactivating tumor-specific immune responses and mobilizing the body's own immune system to combat cancer. GenFleet Therapeutics serves both domestic and international markets, contributing to advancements in cancer therapy through its development of signal transduction regulators, tumor microenvironment modulators, and transcription factors.
Ipoweru.cn is an online education platform based in Beijing, China, founded in 2017. The company specializes in preparing students for college entrance examinations through a variety of offerings including recruitment services, streaming class videos, and online courses. Ipoweru.cn collaborates with professional exam coaches, experts, and professors to provide comprehensive guidance, helping students enhance their competitiveness and avoid common mistakes in the examination process. This approach aims to improve students' chances of admission to their desired colleges.
EpimAb Biotherapeutics is a biopharmaceutical company based in Shanghai, China, focused on the research and development of novel bispecific antibody therapeutics. Utilizing its proprietary Fabs-In-Tandem Immunoglobulin (FIT-Ig) platform, the company creates bispecific molecules that possess antibody-like properties. This innovative approach aims to address the challenges associated with developing effective bi-specific antibodies, which are engineered from two different monoclonal antibodies to combine their therapeutic features into a single entity. These bispecific antibodies hold promise for treating various life-threatening conditions, particularly in immuno-oncology, by offering new therapeutic options. Despite the potential benefits of bi-specific antibodies, many candidates face hurdles in development due to issues related to their binding properties, pharmacokinetics, and production costs. EpimAb Biotherapeutics is positioned to contribute to the growing need for advanced bi-specific therapeutics in the pharmaceutical industry.
Aluksen Technology is an industry leading semiconductor chip manufacturer specializing in optoelectronic technology. The R&D center is located in Silicon Valley, USA. We focus on the telecom, industrial and consumer electronics markets, and gradually form a marketing and service network with Shenzhen as the operation center and covering the global region. We will continue to innovate around customer needs and strive to provide high customers. Quality products and fast, professional technical support and services.
Apollomics is a developer of oncology therapeutics intend to harness the immune system and targeting specific molecular pathways.The company's therapeutics target the growth and proliferation of cancer cells and offer an oral c-Met inhibitor that restores the body's immune system to recognize and kill cancer cells, enabling clients to treat their patients in an enhanced way.
Shenzhen Huahui Technology Co., Ltd. designs and develops quality management and improvement solutions for enterprises. The company also operates as a service provider. Its products include intelligent visualization, multi-dimensional data mining, analysis of information push, resource utilization, and scientific management decision. The company was founded in 2012 and is based in Shenzhen, China.
Leadrive Technology (Shanghai) Co.,Ltd. manufactures homebred power modules and electric vehicle solutions. The company offers products, such as Power Module, Power Control Unit, and Motor. Leadrive Technology (Shanghai) Co.,Ltd. was founded in 2017 and is based in Shanghai, China with additional offices in Shanghai, China; and Aachen, Germany.
Developer of medical information systems intended for hospitals. The company is engaged in the development of medical information systems and medical software for the construction of digital hospitals, medical cost management, patient services, decision making and many more, enabling hospitals to digitize specific operations and improve operational efficiency.
Zhuhai Biyao Technology Co., Ltd. operates an online e-commerce platform that connects consumers directly with quality manufacturers. Founded in 2014 and based in Zhuhai, China, the company offers a diverse range of products including accessories, cosmetics, apparel, furniture, and footwear. Biyao's platform aims to streamline the shopping experience by allowing customers to access high-quality products from renowned designers and manufacturers at factory prices, effectively eliminating intermediaries. This direct-to-consumer approach enhances product availability and affordability for customers.
Producer of Chinese Feng-flavor liquor for customers. The company is committed to the research and development, production and sales of Feng-flavor liquor, providing customers with Chinese-style liquor that does not overwhelm the head, does not dry the throat, and has a pleasant aftertaste.
Sungoal Exhibition Co., Ltd. provides conferences and exhibition services in China. It organizes auto shows and home furnishing material shows. The company was founded in 1995 and is based in Wuhan, China.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.